Since its launch on the European market in March 2016, INNOVO has become the first choice for safe, effective, home treatment for the cause (not just the symptoms) of bladder weakness. INNOVO is currently available in the US, UK, France, Germany, Ireland and the Middle East, with more products planned for the near future. In the U.S., INNOVO is FDA-approved for the treatment of stress urinary incontinence in women. Thousands of healthcare providers and customers around the world rely on Atlantic Therapeutics products to improve the lives of patients with pelvic floor problems. We continue to conduct rigorous clinical trials to further treat bladder weakness with INNOVO.
